Angle Health Raises $200M Series C at $2.7B — Plus a $400M Tender
Vitruvian led Angle Health’s $200M Series C (YC W20) at $2.7B with a $400M tender. Who buys level-funded SMB plans, why profitability matters, and why a European growth firm fits.
Explore our latest articles on y-combinator — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Browse all y-combinator articles below, or use our investor list to research active investors by stage and sector.
Vitruvian led Angle Health’s $200M Series C (YC W20) at $2.7B with a $400M tender. Who buys level-funded SMB plans, why profitability matters, and why a European growth firm fits.
Insight Partners led Kastle’s $24M Series A (YC and Commerce Ventures returning). Agents have processed $1.8B–$2B in lending transactions — who buys bank ops AI and why Insight fits.
Dated coverage for September 15–16, 2026: Grab agreed to buy 60% of Atome Financial for $1.49 billion cash (close targeted Q3 2027). Pulley will cease operations December 8 with Carta as migration partner. Jack & Jill closed $40 million Series A. Reuters reported Anew Labs $290 million at $1.5 billion. Brighteye first-closed Fund III at $72 million.
Pulley’s homepage says the YC W20 cap-table company will cease operations on December 8, 2026 and has an exclusive Carta partnership for customer migration. Business Insider reported more than $50 million raised from Founders Fund, General Catalyst, Stripe, and 8VC. No purchase price for Pulley itself. YC’s directory still said Active on September 16.